Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Clinical Pharmacology and Therapeutics|September 16, 2014
Clopidogrel bioactivation and risk of bleeding in patients cotreated with angiotensin-converting enzyme inhibitors after myocardial infarction: a proof-of-concept studyK E Kristensen, H-J Zhu, X Wang, et al.
Transplantation|July 4, 2001
Human monocytic ehrlichiosis: an emerging pathogen in transplantationH P Tan, J S Dumler, W R Maley, et al.
Archives of General Psychiatry|July 1, 1984
Phenelzine v imipramine in atypical depression. A preliminary reportM R Liebowitz, F M Quitkin, J W Stewart, et al.
The Journal of Clinical Psychiatry|July 1, 1984
Psychopharmacologic validation of atypical depressionM R Liebowitz, F M Quitkin, J W Stewart, et al.
Clinical Pharmacology and Therapeutics|March 7, 2007
Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamicsK S Patrick, A B Straughn, R R Minhinnett, et al.
Transplantation|February 11, 1998
Fas ligand gene transfer to renal allografts in rats: effects on allograft survivalK M Swenson, B Ke, T Wang, et al.
Archives of General Psychiatry|July 1, 1984
The tyramine challenge test as a marker for melancholiaW M Harrison, T B Cooper, J W Stewart, et al.
Annals of Surgery|May 1, 1997
Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experienceJ A Goss, C R Shackleton, D G Farmer, et al.
American Journal of Surgery|May 1, 1997
The impact of microsurgical hepatic arterial reconstruction on the outcome of liver transplantation for congenital biliary atresiaC R Shackleton, J A Goss, K Swenson, et al.
The American Journal of Psychiatry|March 1, 1988
Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI respondersF M Quitkin, J W Stewart, P J McGrath, et al.
Pageof 13